Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |